Why do Cook Medical’s DES and Boston Scientific’s DES produce such different restenotic morphology?

21

Cook Medical’s peripheral arterial disease (PAD) symposium at the 2026 Charing Cross (CX) Symposium (21–23 April, London, UK) included a presentation from Charles Bailey (Emory School of Medicine, Atlanta, USA), who unpacked the data behind the differences between the two drug-eluting stents (DES) and what this means for clinical decision-making.

Click here to watch the full sponsored education.

This video is sponsored by Cook Medical.